Evidence map›Paper›PMID 36630665›Full record

ReviewJCO global oncology2023

Ten Years of the International Cancer Control Partnership: Promoting National Cancer Control Plans to Shape the Health System Response for Cancer Control.

Julie S Torode, Zuzanna Tittenbrun, Yannick Romero, Sonali E Johnson, Jean-Marc Bourque, Leslie S Given, Karin E Hohman, Ernest Hawk, Lisa M Stevens

Abstract readReview
In one paragraph

Review in JCO global oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Julie S TorodeGlobal Oncology Group, Institute of Cancer Policy, Kings College, London, United Kingdom.ORCID 0000-0002-9755-3968
Zuzanna TittenbrunKnowledge, Advocacy and Policy Team, Union for International Cancer Control, Geneva, Switzerland.
Yannick RomeroKnowledge, Advocacy and Policy Team, Union for International Cancer Control, Geneva, Switzerland.ORCID 0000-0003-4698-1126
Sonali E JohnsonKnowledge, Advocacy and Policy Team, Union for International Cancer Control, Geneva, Switzerland.ORCID 0000-0001-8673-9540
Jean-Marc BourqueRadiation Oncology, Center Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada.ORCID 0000-0001-9156-1409
Leslie S GivenStrategic Health Concepts, Arvada, CO.ORCID 0000-0001-9834-8344
Karin E HohmanStrategic Health Concepts, Arvada, CO.ORCID 0000-0002-3529-5692
Ernest HawkDivision of Cancer Prevention & Population Sciences, University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-9062-7338
Lisa M StevensProgramme of Action for Cancer Therapy, International Atomic Energy Agency, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growing premature mortality because of cancer is an increasing public health concern in all countries. This article reviews 10 years of the International Cancer Control Partnership (ICCP) considering the themes of National Cancer Control Plan (NCCP) support, technical assistance, governance, and the renewed momentum of global calls to action. ICCP has provided key resources for the cancer community by hosting a portal with national cancer control and noncommunicable disease (NCD) plans, strategies, guidelines, and key implementation guides for a growing community of best practices. ICCP partners have responded to the changing needs of country planners, adjusting technical guidance as needs evolve from planning to implementation at the national level with an associated shift to peer-to-peer learning and knowledge exchange. The ICCP offer to assist countries in cancer planning continues to be relevant as countries focus on implementation of global initiatives for breast, cervical, and childhood cancers. These initiatives are important to drive priority actions and a systems approach in the emerging road map on NCDs-a message that will be supported by a second global review of NCCPs in 2023. This is critical for driving national action in all countries on cancer and other NCDs in line with global health commitments made for 2030 and adopted by the United Nations General Assemblies. ICCP sees robust systems and financial planning for implementation, monitoring, and evaluation of NCCPs and protection from cancer-related catastrophic expenditure, as critical to longer-term sustainability and success. ICCP calls for national policymakers to prioritize integration of cancer prevention and control into emerging universal health care approaches, including pandemic preparedness/health system resilience and calls for an equity focus in new NCCPs.

Indexed as

NeoplasmsChildGlobal HealthHumansPublic Health

Identifiers

PMID36630665
PMCPMC10166518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.